Advanced Prostate Cancer Consensus Conference: APCCC

Imaging in High Risk Prostate Cancer: Clinicians Perspective - Mark Frydenberg

Details
More from the 2017 APCCC (Advanced Prostate Cancer Consensus Conference): Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

High Risk Locally Advanced Prostate Cancer: What is the Optimal Surgery? - Nicolas Mottet

Details
More videos and content from Nicolas Mottet: EAU Guidelines for patients monitoring under treatment Treatment of M1 Disease No Local Treatment Managing the primary in elderly/unfit patients AUA 2017: How I Screen - Panel More from the 2017 APCCC (Advanced Prostate Cancer Consensus Conference): Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced...

Plasma based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard

Details
Gerhardt Attard focuses on DNA Plasma-based biomarkers in advanced prostate cancer (16 minute presentation). He presents the rationale for using plasma DNA. Plasma collection is routine and are adding to the registries allows for ongoing clinical trials. Circulating tumor DNA is detected in plasma from ALL progressing mCRPC patients. Plasma DNA is representative of clinically relevant progressing...

Radical Prostatectomy vs Radiation and ADT for Prostate Cancer: How Good is the Evidence? - Mack Roach

Details
Mack Roach, III, MD dicusses what is known in radical prostatectomy and radiation and opens this presentation sharing results published recently where the most reliable studies suggest that the differences in 10-year cause-specific survival (CSS) between radical prostatectomy and radiation therapy are small, possible <1%. Further he presents changes in the treatments of radiation therapy in prosta...

Oligometastatic and Oligo-progressive Prostate Cancer: Overview and Definition - Piet Ost

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Oligometastatic and oligo-progressive prostate cancer- Oliver Sartor Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Nuclear Specialist - Stefano Fanti Biography: Prof. Dr. Piet Ost works as Radiation Oncologist at Ghent...

Oligometastatic and Oligo-progressive Prostate Cancer: What Are the Clinicians Needs in This Situation - Oliver Sartor

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Interview with Oliver Sartor from the APCCC

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Radiologist - Anwar Padhani

Details
More from the speaker: Imaging of Metastatic Prostate Cancer- Anwar Padhar More from 2017 Advanced Prostate Cancer Consensus Conference (APCCC): Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Nuclear Specialist - Stefano Fanti

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Radiopharmaceuticals in Prostate Cancer - Stefano Fanti

Epidemiology and Treatment of Advanced Prostate Cancer in India - Vedang Murthy

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Circulating Tumor Cells: Ready for Prime Time? - Interview with Howard Scher

Details
Lecture avaiable here: Howard Scher's presentation at APCCC on: Circulating tumor cells: Ready for Prime time? Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage